pargyline and Phenylketonurias

pargyline has been researched along with Phenylketonurias in 5 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Phenylketonurias: A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952).

Research

Studies (5)

Authors

Other Studies

5 other studies available for pargyline and Phenylketonurias